These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 702768)

  • 61. [In vitro dissolution test: evaluation criterion for prolonged release dosage forms vincamine example (author's transl)].
    Buri P; Doelker E; Boucherat J
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1310-3. PubMed ID: 7279852
    [No Abstract]   [Full Text] [Related]  

  • 62. Influence of cyclandelate on in vitro red blood cell deformability.
    Hall DW; van den Hoven WE
    Drugs; 1987; 33 Suppl 2():30-40. PubMed ID: 3622306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of human platelet functions by cyclandelate.
    van den Hoven WE; Hall DW
    Drugs; 1987; 33 Suppl 2():41-52. PubMed ID: 3304954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Age-associated changes in deoxyglucose uptake in whole brain.
    Le Poncin-Lafitte M; Rapin JR
    Gerontology; 1980; 26(5):265-9. PubMed ID: 7390166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Respiratory effects of vincamine hydrochloride].
    Piacenza G; Pesce E; Marchini F
    Farmaco Prat; 1978 Jul; 33(7):319-25. PubMed ID: 744232
    [No Abstract]   [Full Text] [Related]  

  • 66. In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine.
    Fandy TE; Abdallah I; Khayat M; Colby DA; Hassan HE
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):259-67. PubMed ID: 26666648
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 68. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A; D'Amore I
    Int J Clin Pharmacol Res; 1984; 4(4):277-9. PubMed ID: 6500774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclandelate. An inhibitor of cholesterol esterification.
    Middleton B; Cacciaguerra F; White D
    Drugs; 1987; 33 Suppl 2():75-9. PubMed ID: 3622309
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of intraarterial administered aminophylline on cerebral hemodynamics in man.
    Magnussen I; Hoedt-Rasmussen K
    Acta Neurol Scand; 1977 Feb; 55(2):131-6. PubMed ID: 842284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3',5-trimethylcyclohexanylmandelate).
    Middleton A; White DA; Bell GD; Middleton B
    Biochem Pharmacol; 1983 Oct; 32(20):3079-83. PubMed ID: 6639676
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of vincamine on blood viscosity].
    Ehrly AM; Landgraf H
    Fortschr Med; 1982 May; 100(20):969-71. PubMed ID: 7095712
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute i.v. vincamine teprosilate administration: quantified investigation in elderly subjects.
    Moglia A; Alfonsi E; Zandrini C; Pistarini C; Arrigo A
    Int J Clin Pharmacol Res; 1984; 4(4):303-6. PubMed ID: 6500777
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 75. Effects of vincamin on cerebral metabolism.
    Tesseris J; Roggen G; Caracalos A; Triandafillou D
    Eur Neurol; 1975; 13(3):195-202. PubMed ID: 1149748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Changes in the condition for the use of Cavinton and Devincan. New regulation concerning the prescription and use of these 2 drugs].
    Orv Hetil; 1980 Jun; 121(25):1525-6. PubMed ID: 7454263
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of vincamine on some enzymatic activities from various areas of the beagle dog cerebral cortex.
    Benzi G; Arrigoni E; Pastoris O; Marzatico F; Curti D; Piacenza G; Villa RF
    Farmaco Sci; 1981 Sep; 36(9):811-6. PubMed ID: 7297673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The inhibition of hepatic S-3-hydroxy-3-methylglutaryl-CoA reductase by 3,3,5-trimethylcyclohexanol and its mandelic acid ester, cyclandelate.
    Middleton B; Middleton A; Miciak A; White DA; Bell GD
    Biochem Pharmacol; 1983 Feb; 32(4):649-51. PubMed ID: 6681959
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of acyl coenzyme A: cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate).
    Heffron F; Middleton B; White DA
    Biochem Pharmacol; 1990 Feb; 39(3):575-80. PubMed ID: 2306268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A cholinergic participation in the increase of cerebral cortical blood flow induced by vincamine (rat) (author's transl)].
    Rovere AA
    Acta Physiol Lat Am; 1976; 26(3):206-11. PubMed ID: 1036425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.